title: sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension.
abstract: Utilizing aortopulmonary vascular graft placement, we established a lamb model of pulmonary hypertension that mimics congenital heart disease with increased pulmonary blood flow. We previously demonstrated that endothelial nitric oxide synthase (eNOS) is increased in lambs at age 4 wk. However, these lambs display a selective impairment of endothelium-dependent pulmonary vasodilation that is suggestive of a derangement downstream of NO release. Thus our objective was to characterize potential alterations in the expression and activity of soluble guanylate cyclase (sGC) and phosphodiesterase type 5 (PDE5) induced by increased pulmonary blood flow and pulmonary hypertension. Late-gestational fetal lambs (n = 10) underwent in utero placement of an aortopulmonary vascular graft (shunt). Western blotting analysis on lung tissue from 4-wk-old shunted lambs and age-matched controls showed that protein for both subunits of sGC was increased in shunted lamb lungs compared with age-matched controls. Similarly, cGMP levels were increased in shunted lamb lungs compared with age-matched controls. However, PDE5 expression and activity were also increased in shunted lambs. Thus although cGMP generation was increased, concomitant upregulation of PDE5 expression and activity may have (at least partially) limited and accounted for the impairment of endothelium-dependent pulmonary vasodilation in shunted lambs.
authors.affiliation: Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois 60611-3008, USA. steveblack@northwestern.edu
authors.forename: S M
authors.initials: SM
authors.lastname: Black
authors.forename: L S
authors.initials: LS
authors.lastname: Sanchez
authors.forename: E
authors.initials: E
authors.lastname: Mata-Greenwood
authors.forename: J M
authors.initials: JM
authors.lastname: Bekker
authors.forename: R H
authors.initials: RH
authors.lastname: Steinhorn
authors.forename: J R
authors.initials: JR
authors.lastname: Fineman
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000378:metabolism*; D000818:Animals; D006152:Cyclic GMP / Q000378:metabolism; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D005260:Female; D006162:Guanylate Cyclase; D006976:Hypertension, Pulmonary / Q000378:metabolism / Q000503:physiopathology*; D015151:Immunoblotting; D007150:Immunohistochemistry; D008168:Lung / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D011247:Pregnancy; D011652:Pulmonary Circulation / Q000502:physiology*; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D012756:Sheep; D000071756:Soluble Guanylyl Cyclase
chemical_list: D018160:Receptors, Cytoplasmic and Nuclear; D009569:Nitric Oxide; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D006162:Guanylate Cyclase; D000071756:Soluble Guanylyl Cyclase; D006152:Cyclic GMP